Year Founded
1977
Ownership
Private
Employees
~9000
Therapeutic Areas
PulmonologyCardiovascularImmunologyDermatologyWomen's HealthOncologyNeurology
Stage
Commercial
Modalities
Small moleculeAntibody-based immunotherapyLarge moleculeVaccines (general)

Insud Pharma General Information

Integrated pharmaceutical company with commercial products in women's health, dermatology, and CNS

Contact Information

Website
Primary Industry
[ "CDMO", "Biotech", "Pharma" ]
Corporate Office
Madrid,
Spain

Drug Pipeline

No pipeline data available

For full access to Insud Pharma's pipeline data

Book a demo

Key Partnerships

Agile Therapeutics

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Insud Pharma Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Insud Pharma's complete valuation and funding history, request access »

Insud Pharma Investors

Privately held by founders/shareholders Silvia Gold & Hugo Sigman through Grupo Insud.
Investor Type: Venture Capital
Holding: Minority